Author:
Farris Fred F.,King Franklin G.,Dedrick Robert L.,Litterst Charles L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference58 articles.
1. R. C. DeConti, B. R. Toftness, R. C. Lange, and W. A. Creasey. Clinical and pharmacological studies withcis-dichlorodiammineplatinum(II).Cancer Res. 33:1310–1315 (1973).
2. N. Thatcher, H. Sharma, R. Harrison, A. Smith, A. Zaki, C. A. McAuliffe, D. Crowther, and B. W. Fox. Blood clearance of three radioactively labelled platinum complexes:cis-dichlorodiammineplatinum II,cis, trants-dichlorodihydroxy-bis-(isopropylamine)-platinum IV, andcis-dichloro-bis-cyclopropylamineplatinum II, in patients with malignant disease.Cancer Chemother. Pharmacol. 9:13–16 (1982).
3. A. W. Prestayko, S. T. Cooke, and S. K. Carter (eds.),Cisplatin: Current Status and New Developments. Academic Press, New York, 1980, pp. 317–384.
4. A. W. Prestayko, J. C. D'Aoust, B F. Issell, and S. T. Cooke. Cisplatin (cis-diamminedi-chloroplatinum II).Cancer Treat. Rev. 6:17–39 (1979).
5. D. D. Von Hoff and M. Rozencweig.cis-Diamminedichloroplatinum(II): A metal complex with significant anticancer activity.Adv. Pharmacol. Chemotherapy 16:273–298 (1979).
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献